Authors

Latest:

Dr. Patnaik on a Study Examining SL-401 in Patients With Myeloproliferative Neoplasms

Mrinal S. Patnaik, MBBS, hematologist, Mayo Clinic, discusses a study investigating SL-401 in patients with myeloproliferative neoplasms during the American Society of Hematology (ASH) Annual Meeting.

Murray Korc, MD

Latest:

Combination Therapies Explored in Pancreatic Cancer Subgroups

To address the unmet need for better diagnostic and therapeutic modalities in pancreatic cancer, investigators at the Indiana University School of Medicine have established the Pancreatic Cancer Signature Center at the Indiana University Melvin and Bren Simon Cancer Center.

Murthy R. Chamarthy, MD

Latest:

Liver-Directed Therapy for Hepatic Malignancies

Management of hepatic malignancies requires a multidisciplinary approach, and is based on the tumor burden, liver function, and PS of the patient.

Myeloma

Myrl Weinberg, CAE

Latest:

Developing Optimal Patient Medication Information

Washington, we have a problem. Patients continue to receive prescription medication information, which they often misunderstand or ignore.

Myron S. Czuczman, MD, Roswell Park

N. Patrik Brodin, PhD

Latest:

Montefiore Study May Help Establish Patient Criteria for Proton Therapy

In an effort to build more sophisticated protocols that keep QoL and cost questions at the forefront, Montefiore Einstein Center for Cancer Care and Albert Einstein College of Medicine’s Institute for Onco-Physics created a mathematical model to identify the optimal candidates for proton therapy, the most modern form of radiation therapy for patients with head and neck cancers.

Naamit K. Gerber, MD

Latest:

Dr. Gerber on the Future Landscape of Radiation Oncology

Naamit K. Gerber, MD, assistant professor, Department of Radiation Oncology, NYU Langone’s Perlmutter Cancer Center, discusses the future landscape of radiation oncology.

Nabil Adra, MD, Indiana University Health

Nabil Djouder, PhD

Latest:

Dr. Djouder on the Role of Liver Regeneration in HCC

Nabil Djouder, PhD, discusses the role of liver regeneration in hepatocellular carcinoma.

Nabil F. Saba, MD, FACP

Latest:

Dr Saba on Findings from the CONTINUUM Trial of Sintilimab in Nasopharyngeal Cancer

Nabil F. Saba, MD, FACP, discusses key findings from the phase 3 CONTINUUM trial of sintilimab plus chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma.

Nabil F Saba, MD, FACP, Emory University

Latest:

Managing Adverse Events With Tipifarnib

Recommendations for mitigating and managing treatment-related adverse events associated with tipifarnib.

Nabil P. Rizk, MD, MS, MPH

Latest:

Dr. Rizk on the Evolution of Surgery in Lung Cancer

Nabil P. Rizk, MD, MS, MPH, discusses the evolving role of surgery in lung cancer.

Nadine Abi-Jaoudeh, MD

Latest:

Dr. Abi-Jaoudeh on Combination of Tirapazamine and Transarterial Embolization in HCC

Nadine Abi-Jaoudeh, MD, associate professor, Department of Radiological Sciences, director, Research of Interventional Radiology in the Department of Radiological Sciences, University of California Irvine School of Medicine, discusses the combination of tirapazamine (SR-4233) and transarterial embolization in hepatocellular carcinoma (HCC).

Nadine J. Barrett, PhD

Latest:

Dr. Barrett on Addressing Cancer Disparities

Nadine J. Barrett, PhD, Duke Cancer Institute, discusses the need to address cancer disparities during the Association of Community Cancer Centers (ACCC) 43rd Annual Meeting.

Nadine M. Tung, MD

Latest:

Dr. Tung Discusses the Role of Olaparib in Breast Cancer

Nadine M. Tung, MD, associate professor of medicine, Harvard Medical School, director, Cancer Risk and Prevention Program, Beth Israel Deaconess Medical Center, Dana-Farber Cancer Center, discusses the role of olaparib (Lynparza) in the treatment of patients with breast cancer.

Nadine M. Tung, MD, Harvard Medical School

Nadir Arber, MD, MHA

Latest:

Dr. Arber on Aspirin for Colorectal Cancer Prevention

Nadir Arber, MD, MHA, Yechiel and Helen Lieber Chair for Cancer Research at Tel Aviv Sourasky Medical Center and Tel Aviv University, Sackler School of Medicine, Professor of Medicine and Gastroenterology and Director of the Integrated Cancer Prevention Center (ICPC) in Tel-Aviv Medical Center, discusses the role of aspirin in the prevention of colorectal cancer.

Nagashree Seetharamu, MD

Latest:

Advancement in Treating Uncommon EGFR Mutations: Key Takeaways

Discover the latest insights on treating uncommon EGFR mutations, emphasizing the importance of NGS, personalized therapy, and ongoing advancements in TKIs and ADCs.

Nagi B. Kumar, PhD

Latest:

Nagi Kumar on Green Tea Catechin Treatment for Prostate Cancer Prevention

Nagi B. Kumar, PhD, Professor/Director, Cancer Chemoprevention, Moffitt Cancer Center, discusses the potential of green tea catechins for the prevention of prostate cancer.